Unlock stock picks and a broker-level newsfeed that powers Wall Street.
ASX Penny Stocks To Watch In February 2025

In This Article:

Australian shares are modestly up this morning, with the ASX 200 futures indicating a slight gain as investors await the Reserve Bank of Australia's decision on interest rates. Amidst these developments, penny stocks continue to capture investor interest due to their potential for significant growth. Although the term "penny stocks" may seem outdated, these smaller or less-established companies can offer substantial value when backed by strong financials and clear growth prospects.

Top 10 Penny Stocks In Australia

Name

Share Price

Market Cap

Financial Health Rating

Embark Early Education (ASX:EVO)

A$0.79

A$144.95M

★★★★☆☆

EZZ Life Science Holdings (ASX:EZZ)

A$1.97

A$92.93M

★★★★★★

LaserBond (ASX:LBL)

A$0.575

A$67.47M

★★★★★★

Austin Engineering (ASX:ANG)

A$0.485

A$300.77M

★★★★★☆

IVE Group (ASX:IGL)

A$2.24

A$346.95M

★★★★☆☆

SHAPE Australia (ASX:SHA)

A$3.02

A$250.39M

★★★★★★

Dusk Group (ASX:DSK)

A$1.08

A$67.25M

★★★★★★

GTN (ASX:GTN)

A$0.55

A$108.01M

★★★★★★

Helloworld Travel (ASX:HLO)

A$2.09

A$340.29M

★★★★★★

MaxiPARTS (ASX:MXI)

A$1.84

A$101.78M

★★★★★★

Click here to see the full list of 1,032 stocks from our ASX Penny Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Catapult Group International

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Catapult Group International Ltd is a sports science and analytics company that offers technologies to optimize athlete performance, prevent injuries, and enhance return to play across various regions including Australia, Europe, the Middle East, Africa, the Asia Pacific, and the Americas; it has a market cap of A$1.04 billion.

Operations: Catapult Group International's revenue is derived from three main segments: Performance & Health ($59.49 million), Tactics & Coaching ($34.43 million), and Media & Other ($14.17 million).

Market Cap: A$1.04B

Catapult Group International, a sports science and analytics company, faces challenges as it remains unprofitable with a negative return on equity of -19.58%. Despite this, the company maintains a stable cash runway exceeding three years due to positive free cash flow. Its revenue is expected to grow by 14.61% annually, driven by its Performance & Health segment generating A$59.49 million. Although short-term liabilities surpass short-term assets (A$30.5M vs A$71.7M), long-term liabilities are covered by assets, and there's no significant shareholder dilution recently observed. The experienced board and management team provide stability amid these financial hurdles.


Waiting for permission
Allow microphone access to enable voice search

Try again.